US-based Alkomex to expand its R&D presence in India
ECONOMY & POLICY

US-based Alkomex to expand its R&D presence in India

Global pharmaceutical company Alkomex GBN is planning to expand its research and development presence in India by partnering with nutraceuticals expert Sanjay Agrawal to lead its strategic initiatives in the country.

Alkomex GBN has announced its collaboration with Dr. Sanjay Agrawal, a prominent Indian expert in health management and nutraceuticals, appointing him as the Scientific Advisor for the company.

Alex Meneses Vega, the CEO of Alkomex, mentioned that Agrawal’s leadership would be crucial in driving the company’s growth as it expands its presence in the nutraceutical and functional food sectors.

Agrawal will be based in Ahmedabad and will lead the company’s research and strategic efforts in India. He is expected to guide Alkomex’s R&D initiatives and integrate Indian research into the company's global operations.

The partnership is anticipated to strengthen Alkomex GBN’s ability to develop scientifically-backed nutraceuticals and functional food products aimed at improving global health and wellness, the company stated.

Nutraceuticals are foods, ingredients, or dietary supplements that may offer health or medical benefits.

Global pharmaceutical company Alkomex GBN is planning to expand its research and development presence in India by partnering with nutraceuticals expert Sanjay Agrawal to lead its strategic initiatives in the country. Alkomex GBN has announced its collaboration with Dr. Sanjay Agrawal, a prominent Indian expert in health management and nutraceuticals, appointing him as the Scientific Advisor for the company. Alex Meneses Vega, the CEO of Alkomex, mentioned that Agrawal’s leadership would be crucial in driving the company’s growth as it expands its presence in the nutraceutical and functional food sectors. Agrawal will be based in Ahmedabad and will lead the company’s research and strategic efforts in India. He is expected to guide Alkomex’s R&D initiatives and integrate Indian research into the company's global operations. The partnership is anticipated to strengthen Alkomex GBN’s ability to develop scientifically-backed nutraceuticals and functional food products aimed at improving global health and wellness, the company stated. Nutraceuticals are foods, ingredients, or dietary supplements that may offer health or medical benefits.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code